Dexcom DXCM
NASDAQ DXCM
$84.51 +0.63 (+0.75%)
As of: Sep 10, 2026 · 3:59 PM EDT

Dexcom (DXCM) Long-Term Debt Repayments (2013 - 2023)

Dexcom's (DXCM) quarterly Long-Term Debt Repayments came in at $136.8 million in Q4 2023, up 7947.06% quarter-over-quarter from $1.7 million in Q2 2016.

Analysis

Dexcom (DXCM) Long-Term Debt Repayments (2013 - 2023) Analysis & Trends

Dexcom (DXCM) has reported Long-Term Debt Repayments for 5 consecutive years, with $136.8 million the latest figure, recorded in Q4 2023.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A year-over-year to $136.8 million in Q4 2023; TTM through Dec 2024 was $136.8 million, a 0.0% change from a year earlier, with the FY2023 full-year figure at $787.3 million, changed N/A from the prior year.
  • Long-Term Debt Repayments was $136.8 million for Q4 2023 at Dexcom, up from $1.7 million in the prior quarter.
  • Over five years, Long-Term Debt Repayments peaked at $136.8 million in Q4 2023 and troughed at $136.8 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 1.41 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn -
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn -
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn -
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn -
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn -
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn -
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn -
10 Zimmer Biomet Holdings 17.73 Bn 17.32 Bn 1.54 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 136.80 Mn
Jun 30, 2016 1.70 Mn
Mar 31, 2016 600,000.00
Dec 31, 2015 600,000.00
Sep 30, 2015 500,000.00
Jun 30, 2015 600,000.00
Mar 31, 2015 600,000.00
Dec 31, 2014 600,000.00
Sep 30, 2014 500,000.00
Jun 30, 2014 600,000.00
Mar 31, 2014 500,000.00
Dec 31, 2013 200,000.00